Hong-yang C. Wang

160 Pujian Road
Shanghai, 200127, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 106 publications

Retraction: CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling.

Retraction: CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling.

Journal: Cancer research

Published: May 15, 2026

Targeting the aHSC-PGE2-NK cell axis overcomes immunosuppression and inhibits liver metastasis in fibrotic liver.

Targeting the aHSC-PGE2-NK cell axis overcomes immunosuppression and inhibits liver metastasis in fibrotic liver.

Journal: Cancer letters

Published: November 16, 2025

Evaluation of binding, affinity and metabolic regulatory activity of a transketolase inhibitor.

Evaluation of binding, affinity and metabolic regulatory activity of a transketolase inhibitor.

Journal: Methods in enzymology

Published: November 07, 2025

TiN-Based Photothermal Fabric with a Superhydrophobic Surface for Synergistic Anti-/Deicing.

TiN-Based Photothermal Fabric with a Superhydrophobic Surface for Synergistic Anti-/Deicing.

Journal: Langmuir : the ACS journal of surfaces and colloids

Published: August 25, 2025

Lidocaine potentiates thermal ablation in cholangiocarcinoma by modulating TRPV6-Driven Ca2+/PI3K/AKT/HSF-1 signaling pathway.

Lidocaine potentiates thermal ablation in cholangiocarcinoma by modulating TRPV6-Driven Ca2+/PI3K/AKT/HSF-1 signaling pathway.

Journal: Cancer letters

Published: August 06, 2025

Targeting the Osteopontin-regulated PI3K/AKT signaling pathway: A molecular approach to overcome drug resistance and metastasis in gastrointestinal tumors.

Targeting the Osteopontin-regulated PI3K/AKT signaling pathway: A molecular approach to overcome drug resistance and metastasis in gastrointestinal tumors.

Journal: World journal of gastrointestinal oncology

Published: May 27, 2025

Hepatocellular Carcinoma Risk Stratification for Cirrhosis Patients: Integrating Radiomics and Deep Learning Computed Tomography Signatures of the Liver and Spleen into a Clinical Model.

Hepatocellular Carcinoma Risk Stratification for Cirrhosis Patients: Integrating Radiomics and Deep Learning Computed Tomography Signatures of the Liver and Spleen into a Clinical Model.

Journal: Journal of clinical and translational hepatology

Published: February 26, 2025

Amelioration of Liver Fibrosis via In Situ Hepatic Stellate Cell Conversion Through Co-Inhibition of TGF-β and GSK-3 Signalling.

Amelioration of Liver Fibrosis via In Situ Hepatic Stellate Cell Conversion Through Co-Inhibition of TGF-β and GSK-3 Signalling.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 07, 2025

Carbon Nanofiber Membranes Loaded with MXene@g-C3N4: Preparation and Photocatalytic Property.

Carbon Nanofiber Membranes Loaded with MXene@g-C3N4: Preparation and Photocatalytic Property.

Journal: Nanomaterials (Basel, Switzerland)

Published: April 23, 2024

Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trial.

Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trial.

Journal: Clinical and translational medicine

Published: January 19, 2024

Deciphering the Multifaceted Immune Landscape of Unresectable Primary Liver Cancer to Predict Immunotherapy Response.

Deciphering the Multifaceted Immune Landscape of Unresectable Primary Liver Cancer to Predict Immunotherapy Response.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 10, 2023

Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis.

Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis.

Journal: Cancer letters

Published: December 02, 2023

Showing 1-12 of 106

Last Updated: 09/26/2026